Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Loss of LUC7L2 and U1 snRNP subunits shifts energy metabolism from glycolysis to OXPHOS.

Molecular cell | 2021

Oxidative phosphorylation (OXPHOS) and glycolysis are the two major pathways for ATP production. The reliance on each varies across tissues and cell states, and can influence susceptibility to disease. At present, the full set of molecular mechanisms governing the relative expression and balance of these two pathways is unknown. Here, we focus on genes whose loss leads to an increase in OXPHOS activity. Unexpectedly, this class of genes is enriched for components of the pre-mRNA splicing machinery, in particular for subunits of the U1 snRNP. Among them, we show that LUC7L2 represses OXPHOS and promotes glycolysis by multiple mechanisms, including (1) splicing of the glycolytic enzyme PFKM to suppress glycogen synthesis, (2) splicing of the cystine/glutamate antiporter SLC7A11 (xCT) to suppress glutamate oxidation, and (3) secondary repression of mitochondrial respiratory supercomplex formation. Our results connect LUC7L2 expression and, more generally, the U1 snRNP to cellular energy metabolism.

Pubmed ID: 33852893 RIS Download

Antibodies used in this publication

Associated grants

  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007287
  • Agency: Howard Hughes Medical Institute, United States
  • Agency: NIGMS NIH HHS, United States
    Id: R35 GM122455
  • Agency: NHGRI NIH HHS, United States
    Id: U41 HG009889
  • Agency: NHGRI NIH HHS, United States
    Id: R01 HG004659
  • Agency: NIGMS NIH HHS, United States
    Id: F32 GM133047
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM085319

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Clustal Omega (tool)

RRID:SCR_001591

Software package as multiple sequence alignment tool that uses seeded guide trees and HMM profile-profile techniques to generate alignments between three or more sequences. Accepts nucleic acid or protein sequences in multiple sequence formats NBRF/PIR, EMBL/UniProt, Pearson (FASTA), GDE, ALN/Clustal, GCG/MSF, RSF.

View all literature mentions

Gene Set Enrichment Analysis (tool)

RRID:SCR_003199

Software package for interpreting gene expression data. Used for interpretation of a large-scale experiment by identifying pathways and processes.

View all literature mentions

GOrilla: Gene Ontology Enrichment Analysis and Visualization Tool (tool)

RRID:SCR_006848

A tool for identifying and visualizing enriched GO terms in ranked lists of genes. It can be run in one of two modes: * Searching for enriched GO terms that appear densely at the top of a ranked list of genes or * Searching for enriched GO terms in a target list of genes compared to a background list of genes.

View all literature mentions

Program to Reduce Incontinence by Diet and Exercise (tool)

RRID:SCR_009018

Randomized controlled trial being conducted at two clinical centers in the United States to learn more about the effects of weight loss on urinary incontinence. About 330 overweight women aged 30 or older will participate and will be followed for 18 months. Efficacy of weight reduction as a treatment for urinary incontinence will be examined at 6 months following the intensive weight control program, and the sustained impact of the intervention will be examined at 18 months. To increase the maintenance of weight reduction and facilitate evaluation of the enduring impact of weight loss on urinary incontinence, they propose to study a motivation-based weight maintenance program. At the end of the intensive weight control program, women randomized to the weight loss program will be randomized to either a 12-month skill-based maintenance intervention or to a motivation-based maintenance intervention. The maintenance interventions maximize the potential for sustained weight loss and will allow them to determine if long-term weight reduction will produce continued improvement in urinary incontinence.

View all literature mentions

Multivariate Analysis of Transcript Splicing (tool)

RRID:SCR_013049

Software tool to detect differential alternative splicing events from RNA-Seq data. Calculates P value and false discovery rate that difference in isoform ratio of gene between two conditions exceeds given user defined threshold. Can automatically detect and analyze alternative splicing events corresponding to all major types of alternative splicing patterns. Handles replicate RNA-Seq data from both paired and unpaired study design.

View all literature mentions

DESeq2 (tool)

RRID:SCR_015687

Software package for differential gene expression analysis based on the negative binomial distribution. Used for analyzing RNA-seq data for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates.

View all literature mentions

Fructose 6 Phosphate Kinase antibody (antibody)

RRID:AB_10680060

This polyclonal targets Fructose 6 Phosphate Kinase antibody

View all literature mentions

beta Tubulin Loading Control Monoclonal Antibody (BT7R) (antibody)

RRID:AB_2537819

This monoclonal targets beta Tubulin Loading Control

View all literature mentions

Tom20 (FL-145) Antibody (antibody)

RRID:AB_2207533

This polyclonal targets Tom20 (FL-145)

View all literature mentions

xCT/SLC7A11 (D2M7A) Rabbit Antibody (antibody)

RRID:AB_2687474

This monoclonal targets xCT/SLC7A11

View all literature mentions

PGAM1 (antibody)

RRID:AB_2736922

This monoclonal targets PGAM1

View all literature mentions

PFKP (D4B2) Rabbit mAb (antibody)

RRID:AB_2713957

This monoclonal targets PFKP

View all literature mentions

Anti-LUC7L3 antibody produced in rabbit (antibody)

RRID:AB_1847248

This unknown targets Human AC005921.3-1

View all literature mentions

Anti-LUC7L2 polyclonal antibody (antibody)

RRID:AB_2681558

This polyclonal targets LUC7L2

View all literature mentions

LUC7L (43-I) (antibody)

RRID:AB_2139473

This monoclonal targets LUC7L

View all literature mentions

IRDye 800CW Goat anti-Rabbit IgG (antibody)

RRID:AB_621843

This polyclonal secondary targets IgG

View all literature mentions

anti-actin (antibody)

RRID:AB_2737344

This monoclonal targets actin

View all literature mentions

HeLa (cell line)

RRID:CVCL_0030

Cell line HeLa is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions

HEK293T (cell line)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

K-562 (cell line)

RRID:CVCL_0004

Cell line K-562 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions